A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma-Reference-Cited by-同舟云学术

A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma

Published:2014-10-13 Issue:4 Volume:121 Page:570-579
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chawla Sant P.¹,Chua Victoria S.¹,Hendifar Andrew F.¹,Quon Doris V.¹,Soman Neelesh¹,Sankhala Kamalesh K.²,Wieland D. Scott³,Levitt Daniel J.³

Affiliation:

1. Sarcoma Oncology CenterSanta Monica California

2. Institute for Drug DevelopmentCancer Therapy and Research CenterUniversity of Texas Health Science CenterSan Antonio Texas

3. CytRx CorporationLos Angeles California

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.29081

Reference26 articles.

1. American Cancer Society. Cancer Facts & Figures 2013.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer‐facts‐figures‐2013. Accessed July 8 2014.

2. National Cancer Institute. SEER Stat Fact Sheets: Leukemia.seer.cancer.gov/statfacts/html/leuks.html. Accessed July 8 2014.

3. National Comprehensive Cancer Network. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology Soft Tissue Sarcoma. Version 2.2014.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf. Accessed July 8 2014.

4. Optimizing Clinical Care in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of a New Schedule of High-Dose Continuous Infusion Ifosfamide and Doxorubicin Combination

5. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aldoxorubicin in soft tissue sarcomas;Future Oncology;2019-05

Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date

;OncoTargets and Therapy;2019-03

3. Successes, failures, and future prospects of prodrugs and their clinical impact;Expert Opinion on Drug Discovery;2019-02-04

4. Aldoxorubicin therapy for the treatment of patients with advanced soft tissue sarcoma;Future Oncology;2018-10

5. Functional Peptide Nanofibers with Unique Tumor Targeting and Enzyme-Induced Local Retention Properties;Advanced Functional Materials;2018-09-14